Condition
Transformed Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Transformed Lymphoma clinical trials that are recruiting, at sites in 3 countries (most in United States (4), Canada (1), China (1)). By phase: Phase 2 (3), Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Transformed Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Evaluating POLA-R-CHP for treating transformed DLBCL | Phase 2 | Shanghai, Shanghai Municipality | Recruiting | Dec 20, 2024 |
| Local production of CAR T-cells for treating B-Cell cancers | Phase 2 | Pittsburgh, Pennsylvania | Recruiting | Mar 16, 2022 |
| Using acalabrutinib to prevent relapse in patients with large B-cell lymphoma | Phase 1/2 | Los Angeles, California and 2 other locations | Recruiting | Feb 25, 2022 |
| CAR-T cell therapy for relapsed or refractory DLBCL | Phase 2 | Birmingham, Alabama and 31 other locations | Recruiting | Mar 11, 2021 |
| Using modified T cells to treat relapsed or refractory Non-Hodgkin Lymphoma | Phase 1 | San Francisco, California | Recruiting | Sep 11, 2020 |
All recruiting trials (5)
-
Evaluating POLA-R-CHP for treating transformed DLBCL
This study is testing a new treatment called POLA-R-CHP to see if it can help people with transformed diffuse large B-cell lymphoma feel better and improve their outcomes.
-
Local production of CAR T-cells for treating B-Cell cancers
This study is testing whether making CAR T-cells locally can help patients with B-Cell lymphoma and leukemia have a safe and effective treatment.
-
Using acalabrutinib to prevent relapse in patients with large B-cell lymphoma
This study is testing if the drug acalabrutinib can help prevent cancer from coming back in patients with large B-cell lymphoma who are at high risk after treatment.
-
CAR-T cell therapy for relapsed or refractory DLBCL
This study is testing a new CAR-T cell therapy to see if it can help people with tough-to-treat diffuse large B cell lymphoma feel better after other treatments haven’t worked.
-
Using modified T cells to treat relapsed or refractory Non-Hodgkin Lymphoma
This study is testing a new treatment using modified T cells to see if it can help people with relapsed or hard-to-treat Non-Hodgkin Lymphoma.
Related topics
Quick answers
How many Transformed Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (4 trials), Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.